Eli Lilly’s recent announcement of a raised revenue forecast due to strong demand for its weight-loss treatment Zepbound and related diabetes drug
Eli Lilly’s recent announcement of a raised revenue forecast due to strong demand for its weight-loss treatment Zepbound and related diabetes drug